Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea Source: Eur Respir J 2011; 37: 89-97 Year: 2011
Oxidative stress and inflammation in OSA Source: Eur Respir Mon 2010; 50: 360-380 Year: 2010
Relationship of oxidative stress and endothelial dysfunction in sleep apnoea Source: Eur Respir J 2011; 37: 873-879 Year: 2011
Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link Source: Eur Respir J 2009; 33: 1467-1484 Year: 2009
Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome Source: Eur Respir J 2008; 31: 1046-1053 Year: 2008
Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009
8-isoprostanes and resistin as markers of vascular damage in non-hypersomnolent obstructive sleep apnea patients Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea Source: Eur Respir J 2009; 34: 1390-1398 Year: 2009
Evaluation of 8-isoprostane as a biomarker of oxidative stress in children with obstructive sleep apnea syndrome Source: Annual Congress 2012 - Sleep monitoring, lung function and inflammation in childhood Year: 2012
Impaired restorative sleep, endotoxaemia and oxidative stress in women with obstructive sleep apnoea Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude Year: 2019
Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia Source: Eur Respir J 2012; 39: 1492-1500 Year: 2012
Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea Source: Eur Respir J 2009; 33: 793-796 Year: 2009
Obstructive sleep apnoea and COPD Source: Eur Respir Mon 2013; 59: 135-143 Year: 2013
Sleep apnoea, hypertension and vascular disease: where are we now? Source: Eur Respir Rev 2007; 16: 169-182 Year: 2007
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
The influence of glucose tolerance on plasma oxidative stress markers in obstructive sleep apnea males Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly Source: Eur Respir J 2009; 33: 797-803 Year: 2009
Is snoring the cause of oxidative stress in airways in obstructive sleep apnea patients? Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007